Orteronel

Please request pricing for this article.
Request Pricing

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
TGM-T6051-50mg	50 mg				7 - 10 business days*		-
TGM-T6051-100mg	100 mg				7 - 10 business days*		-

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Orteronel ((S)-Orteronel)(TAK-700) was selected as a candidate for clinical... more

Close menu

Product information "Orteronel"

Description: Orteronel ((S)-Orteronel)(TAK-700) was selected as a candidate for clinical evaluation. orteronel (TAK-700) is currently in phase III clinical trials for the treatment of castration-resistant prostate cancer. Target: P450. Smiles: CNC(=O)c1ccc2cc(ccc2c1)[C@@]1(O)CCn2cncc12. References: Yamaoka M, et al. Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys. J Steroid Biochem Mol Biol. 2012 Apr,129(3-5):115-28.

Keywords:	(S)-Orteronel, TAK-700
Supplier:	TargetMol
Supplier-Nr:	T6051

Properties

Application:	Targets steroid 17alpha-monooxygenase / 17alpha-hydroxyprogesterone deacetylase (CYP17A)
MW:	307.35 D
Formula:	C18H17N3O2
Format:	32160405

Database Information

CAS :	566939-85-3\| Matching products
KEGG ID :	K00512 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Orteronel"

Write a review